11. Current evidence on the use of the adalimumab biosimilar SB5 (ImraldiTM): a multidisciplinary perspective. (1st February 2022) Authors: Gisbert, Javier P.; Gaffney, Karl; Young, David; Ebbers, Hans C.; Girolomoni, Giampiero Journal: Expert opinion on biological therapy Issue: Volume 22:Number 2(2022) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Defining the target: clinical aims in axial spondyloarthritis. (16th November 2018) Authors: Marzo-Ortega, Helena; Gaffney, Katie M; Gaffney, Karl Journal: Rheumatology Issue: Volume 57(2018)Supplement 6 Page Start: vi18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Delay to diagnosis in axial spondyloarthritis: are we improving in the UK?. (17th August 2015) Authors: Sykes, Mark P.; Doll, Helen; Sengupta, Raj; Gaffney, Karl Journal: Rheumatology Issue: Volume 54:Number 12(2015:Dec.) Page Start: 2283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Delayed diagnosis in axial spondyloarthritis—how can we do better?. (9th July 2021) Authors: Gaffney, Karl; Webb, Dale; Sengupta, Raj Journal: Rheumatology Issue: Volume 60:Number 11(2021) Page Start: 4951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit. (12th May 2021) Authors: Russell, Mark D; Coath, Fiona; Yates, Mark; Bechman, Katie; Norton, Sam; Galloway, James B; Ledingham, Joanna; Sengupta, Raj; Gaffney, Karl Journal: Rheumatology Issue: Volume 61:Number 2(2022) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Does the co-existence of acute anterior uveitis and chronic back pain prompt primary care physicians to consider a diagnosis of axial spondyloarthritis?. Issue 4 (20th January 2016) Authors: Maxwell, Alexander; Yates, Max; Everden, Paul; Gaffney, Karl Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 4(2016) Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Dr Andrew Charles Scott Keat, MBBS MD FRCP (1949–2022). (8th April 2022) Authors: Marzo-Ortega, Helena; van Rossen, Liz; Gaffney, Karl Journal: Rheumatology Issue: Volume 61:Number 8(2022) Page Start: 3502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. E098 Efficacy and safety outcomes in patients with axial spondyloarthritis treated with certolizumab pegol: results from the 48-week run-in part of a 96-week study (NCT02505542). (12th April 2019) Authors: Landewe, Robert; van der Heijde, Desiree; Dougados, Maxime; Baraliakos, Xenofon; den Bosch, Filip Van; Gaffney, Karl; Hoepken, Bengt; Thomas, Karen; Gensler, Lianne S Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. Issue 9 (September 2022) Authors: Abhishek, Abhishek; Boyton, Rosemary J; Peckham, Nicholas; McKnight, Áine; Coates, Laura C; Bluett, James; Barber, Vicki; Cureton, Lucy; Francis, Anne; Appelbe, Duncan; Eldridge, Lucy; Julier, Patrick; Valdes, Ana M; Brooks, Tim; Rombach, Ines; Altmann, Daniel M; Nguyen-Van-Tam, Jonathan S; Willi... Journal: Lancet Issue: Volume 10:Issue 9(2022) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Issue 4 (17th January 2023) Authors: van der Heijde, Désirée; Deodhar, Atul; Baraliakos, Xenofon; Brown, Matthew A; Dobashi, Hiroaki; Dougados, Maxime; Elewaut, Dirk; Ellis, Alicia M; Fleurinck, Carmen; Gaffney, Karl; Gensler, Lianne S; Haroon, Nigil; Magrey, Marina; Maksymowych, Walter P; Marten, Alexander; Massow, Ute; Oortgiesen,... Journal: Annals of the rheumatic diseases Issue: Volume 82:Issue 4(2023) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗